438 related articles for article (PubMed ID: 15809529)
1. Molecular signaling pathways regulating muscle proteolysis during atrophy.
Franch HA; Price SR
Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):271-5. PubMed ID: 15809529
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling.
Wang X; Hu Z; Hu J; Du J; Mitch WE
Endocrinology; 2006 Sep; 147(9):4160-8. PubMed ID: 16777975
[TBL] [Abstract][Full Text] [Related]
3. Signaling pathways perturbing muscle mass.
Glass DJ
Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):225-9. PubMed ID: 20397318
[TBL] [Abstract][Full Text] [Related]
4. Identification of pathways controlling muscle protein metabolism in uremia and other catabolic conditions.
Du J; Mitch WE
Curr Opin Nephrol Hypertens; 2005 Jul; 14(4):378-82. PubMed ID: 15931008
[TBL] [Abstract][Full Text] [Related]
5. Cellular signals activating muscle proteolysis in chronic kidney disease: a two-stage process.
Du J; Hu Z; Mitch WE
Int J Biochem Cell Biol; 2005 Oct; 37(10):2147-55. PubMed ID: 15982920
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle hypertrophy and atrophy signaling pathways.
Glass DJ
Int J Biochem Cell Biol; 2005 Oct; 37(10):1974-84. PubMed ID: 16087388
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms modulating muscle mass.
Glass DJ
Trends Mol Med; 2003 Aug; 9(8):344-50. PubMed ID: 12928036
[TBL] [Abstract][Full Text] [Related]
8. Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase.
Lee SW; Dai G; Hu Z; Wang X; Du J; Mitch WE
J Am Soc Nephrol; 2004 Jun; 15(6):1537-45. PubMed ID: 15153564
[TBL] [Abstract][Full Text] [Related]
9. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
[TBL] [Abstract][Full Text] [Related]
10. The ubiquitin-proteasome system and skeletal muscle wasting.
Attaix D; Ventadour S; Codran A; Béchet D; Taillandier D; Combaret L
Essays Biochem; 2005; 41():173-86. PubMed ID: 16250905
[TBL] [Abstract][Full Text] [Related]
11. Strategies for suppressing muscle atrophy in chronic kidney disease: mechanisms activating distinct proteolytic systems.
Mitch WE; Hu Z; Lee SW; Du J
J Ren Nutr; 2005 Jan; 15(1):23-7. PubMed ID: 15648002
[TBL] [Abstract][Full Text] [Related]
12. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
Stitt TN; Drujan D; Clarke BA; Panaro F; Timofeyva Y; Kline WO; Gonzalez M; Yancopoulos GD; Glass DJ
Mol Cell; 2004 May; 14(3):395-403. PubMed ID: 15125842
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory cytokines and skeletal muscle.
Späte U; Schulze PC
Curr Opin Clin Nutr Metab Care; 2004 May; 7(3):265-9. PubMed ID: 15075917
[TBL] [Abstract][Full Text] [Related]
14. Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction.
Schulze PC; Fang J; Kassik KA; Gannon J; Cupesi M; MacGillivray C; Lee RT; Rosenthal N
Circ Res; 2005 Sep; 97(5):418-26. PubMed ID: 16051886
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.
Tisdale MJ
J Support Oncol; 2005; 3(3):209-17. PubMed ID: 15915823
[TBL] [Abstract][Full Text] [Related]
16. Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome.
Sandri M
Int J Biochem Cell Biol; 2013 Oct; 45(10):2121-9. PubMed ID: 23665154
[TBL] [Abstract][Full Text] [Related]
17. Is there a common mechanism linking muscle wasting in various disease types?
Tisdale MJ
Curr Opin Support Palliat Care; 2007 Dec; 1(4):287-92. PubMed ID: 18685377
[TBL] [Abstract][Full Text] [Related]
18. Muscle wasting from kidney failure-a model for catabolic conditions.
Wang XH; Mitch WE
Int J Biochem Cell Biol; 2013 Oct; 45(10):2230-8. PubMed ID: 23872437
[TBL] [Abstract][Full Text] [Related]
19. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
Glass DJ
Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of MuRF1 and MAFbx participates to muscle wasting upon gentamicin-induced acute kidney injury.
Aniort J; Polge C; Claustre A; Combaret L; Béchet D; Attaix D; Heng AE; Taillandier D
Int J Biochem Cell Biol; 2016 Oct; 79():505-516. PubMed ID: 27102410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]